AHC Media - Continuing Medical Education Publishing

The most award winning

healthcare information source.

TRUSTED FOR FOUR DECADES.

  • Sign In
  • Sign Out
  • MyAHC
    • Home
      • Home
      • Newsletters
      • Blogs
      • Archives
      • CME/CE Map
      • Shop
    • Emergency
      • All Products
      • Publications
      • Study Guides
      • Live Webinars
      • On-Demand Webinars
      • Libraries
    • Hospital
      • All Products
      • Publications
      • Study Guides
      • Live Webinars
      • On-Demand Webinars
      • Libraries
    • Clinical
      • All Products
      • Publications
      • Study Guides
      • Live Webinars
      • On-Demand Webinars
    • My Account
      • My Subscriptions
      • My Content
      • My Orders
      • My CME/CE
      • My Transcript
    Home » Stroke Risk in Atrial Fibrillation: A Moving Target?
    ABSTRACT & COMMENTARY

    Stroke Risk in Atrial Fibrillation: A Moving Target?

    April 15, 2018
    No Comments
    Reprints
    Facebook Twitter Linkedin Share Share

    Related Articles

    Elderly Women with Atrial Fibrillation Have a Greater Risk of Stroke than Men

    Stroke Prevention by Screening for Atrial Fibrillation

    Stroke Prevention in Patients with Atrial Fibrillation

    Related Products

    Clinical Cardiology Alert: Online, 1 Year Subscription

    Stroke 2018: The Cutting Edge – PDF Download

    STROKE: The Cutting Edge: 2017 - PDF Download

    Related Events

    Why is Aligning Acute and Post-Acute Care Providers Important in Transitional Planning?

    CMS to Hospitals: How to Overcome the QAPI Worksheet and Standards

    What is Your Benchmark for Measuring Case Management Outcomes?

    By Michael H. Crawford, MD

    Professor of Medicine, Chief of Clinical Cardiology, University of California, San Francisco

    Dr. Crawford reports no financial relationships relevant to this field of study.

    SYNOPSIS: An investigation of patients in a national database with atrial fibrillation, no comorbidities, and not on aspirin or anticoagulants showed that the clinical features that make up the CHA2DS2-VASc score change over time and can increase a patient’s risk for stroke, which could affect therapy decisions. Thus, the CHA2DS2-VASc score should be reassessed periodically and appropriate therapeutic actions taken promptly.

    SOURCES: Chao TF, Lip GYH, Liu CJ, et al. Relationship of aging and incident comorbidities to stroke risk in patients with atrial fibrillation.
    J Am Coll Cardiol 2018;71:122-132.

    Gage BF. Stroke prediction rules in atrial fibrillation. J Am Coll Cardiol 2018;71:133-134.

    The authors of previous studies of stroke risk in patients with atrial fibrillation (AF) have assessed the risk factors imbedded in the CHA2DS2-VASc score at baseline and then observed the patients during years of follow up. However, as these patients age, comorbidities that affect their risk often change.

    Investigators from Taiwan hypothesized that changes in the CHA2DS2-VASc score would carry greater predictive value than the baseline score. From the Taiwan National Health Insurance database, 31,039 patients with AF who were not on antiplatelet or anticoagulant drugs and did not exhibit any features in the CHA2DS2-VASc scheme (except age and sex) were identified from 1996-2009. In this group, 4,103 experienced a stroke during follow-up. The follow-up CHA2DS2-VASc score was the highest measured before the occurrence of stroke, mortality, or the end of 2009. The difference between the baseline and follow-up CHA2DS2-VASc score (delta) and the slope of the score change were calculated.

    During follow-up, the mean age increased from 64 to 68 years and the delta CHA2DS2-VASc was 1.02. The baseline, follow-up, and delta CHA2DS2-VASc scores were higher in those who experienced a stroke. About 52% of patients acquired a new comorbidity that affected the CHA2DS2-VASc score, most commonly hypertension (37%), heart failure (27%), and diabetes (13%). CHA2DS2-VASc remained unchanged in only 41% of patients. The delta CHA2DS2-VASc score predicted stroke (hazard ratio, 1.52; 95% confidence interval, 1.48-1.56; P < 0.001) and performed better than baseline or follow-up CHA2DS2-VASc. The area under the receiver operating curve (AUC) was 0.74 for delta CHA2DS2-VASc, compared to 0.58 for baseline and 0.73 for follow-up. Also, the slope of the delta CHA2DS2-VASc was higher in those with stroke compared to those without (0.58 vs. 0.42; P < 0.001).

    The authors concluded that the CHA2DS2-VASc score is not static over time and most patients with AF develop one or more new comorbidities that affect the CHA2DS2-VASc score in addition to aging. This increment in the CHA2DS2-VASc score also was highly predictive of stroke.

    COMMENTARY

    In some ways, the results of this study are obvious. If one acquires risk factors for stroke over time, the risk of stroke increases. Since this has not been investigated or proven, this study is of interest. The main finding of the study is that the AUC of the follow-up CHA2DS2-VASc score is significantly higher than that of the baseline score (0.74 vs. 0.58). However, considering that at baseline all patients included in this study exhibited no comorbidities and registered CHA2DS2-VASc scores of 0 for men and 1 for women, this, too, is unsurprising. One would expect that as patients with AF age they would pick up comorbidities that affect the CHA2DS2-VASc score, as most subjects in this study did. What is perhaps the most interesting finding in this study is that soon after an increase in the CHA2DS2-VASc score, the risk of stroke is higher than later. The editorialist for this article suggested that this is because new comorbidities may not be well controlled early after diagnosis. He noted that the risk of stroke is high early after a transient ischemic attack but decreases over time. The same may be true for newly diagnosed hypertension, heart failure, or diabetes.

    There are limitation to this study. It was an insurance database study, and all diagnoses were made by the patient’s own physicians. However, the authors noted that the accuracy of this approach has been validated previously in the Taiwan database. There are no laboratory data available, so the influence of biomarkers cannot be ascertained. Although they assessed the value of changes in the CHA2DS2-VASc score, the authors explicitly stated that they are not proposing a new measure of delta CHA2DS2-VASc. The authors only showed these data to bolster their point that changes in the CHA2DS2-VASc over time must be considered and therapeutic changes made as appropriate to reduce the rising risk of stroke.

    Post a comment to this article

    Report Abusive Comment

    www.ahcmedia.com

    Internal Medicine Alert

    View PDF
    Internal Medicine Alert (Vol. 40, No. 7) - April 15, 2018
    April 15, 2018

    Table Of Contents

    Elderly May Not Benefit From Statins for Primary Prevention

    Stroke Risk in Atrial Fibrillation: A Moving Target?

    After Myocardial Infarction, Increased Risk for Ischemic Stroke Persists for 12 Weeks

    Ibalizumab-uiyk Injection (Trogarzo)

    Clinical Briefs

    What Form of AV Block?

    Begin Test

    Buy this Issue/Course

    Pharmacology Watch

    Feedback? Please take our annual survey

    Financial Disclosure: Internal Medicine Alert’s Physician Editor Stephen Brunton, MD, is a retained consultant for Abbott Diabetes, Becton Dickinson, Boehringer Ingelheim, Janssen, Lilly, Merck, Novo Nordisk, and Sanofi; he serves on the speakers bureau of AstraZeneca, Boehringer Ingelheim, Janssen, Lilly, and Novo Nordisk. Contributing Editor Louis Kuritzky, MD, is a consultant for and on the speakers bureau of Amgen, Boehringer Ingelheim, and Shire. Peer Reviewer Gerald Roberts, MD; Editor Jonathan Springston; Executive Editor Leslie Coplin; and Editorial Group Manager Terrey L. Hatcher report no financial relationships relevant to this field of study.

    Shop Now: Search Products

    • Subscription Publications
    • Books & Study Guides
    • Group & Site
      Licenses
    • Upcoming Live Webinars
    • On-Demand Webinars
    • State CME/CE
      Requirements

    Webinars And Events

    Pain Management 101: CMS Opioid, IV Medication, and Blood Transfusion Guidelines

    May 1 2018, 3:30pm EDT
    Live Webinar

    2018 Case Management Boot Camp Series: Going Beyond Basics

    May 2 2018, 1:00pm EDT
    Live Webinar

    Crafting the Perfect Collaboration: How do You Align Hospitalists, Physician Advisors, ED Physicians, and Other Heavy Hitters?

    May 2 2018, 1:00pm EDT
    Live Webinar
    View All Events

    Free Email Newsletters

    • Accreditation Council for Continuing Medical Education
    • American Nurses Credentialing Center
    • American College of Emergency Physician
    • American Board of Internal Medicine: Maintenance of Certification
    • California Board of Registered Nursing
    • Commission for Case Manager Certification
    • American Academy of Pediatrics
    • American Osteopathic Association
    • Stand Up for Kids
    • Home
      • Home
      • Newsletters
      • Blogs
      • Archives
      • CME/CE Map
      • Shop
    • Emergency
      • All Products
      • Publications
      • Study Guides
      • Live Webinars
      • On-Demand Webinars
      • Libraries
    • Hospital
      • All Products
      • Publications
      • Study Guides
      • Live Webinars
      • On-Demand Webinars
      • Libraries
    • Clinical
      • All Products
      • Publications
      • Study Guides
      • Live Webinars
      • On-Demand Webinars
    • My Account
      • My Subscriptions
      • My Content
      • My Orders
      • My CME/CE
      • My Transcript
    • Help
    • Search
    • About Us
    • Sign In
    • Register
    AHC Media - Continuing Medical Education Publishing

    The most award winning

    healthcare information source.

    TRUSTED FOR FOUR DECADES.

    Customer Service

    Customer.Service@AHCMedia.com

    U.S. and Canada: 1-800-688-2421

    International +1-404-262-5476

    Accounts Receivable

    1-800-370-9210
    ahcmedia_ar@reliaslearning.com

    Mailing Address

    • 111 Corning Road, Suite 250
      Cary, NC 27518
      USA

    © 2018 Relias. All rights reserved.

    Privacy Policy  Terms of Use  Contact Us  Reprints  Group Sales

    Design, CMS, Hosting & Web Development :: ePublishing